| Application no. and date | 08001340.2 (espacenet) (Federated) (European Patent Register), 20010702 | | Patent/reg. no. and date | DK/EP 1935427, 20180307 | | Publication date | 20080625 | | Priority no. and date | US 215913 P, 20000703 | | EP pub. no. and date |
EP 1935427 20080625 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V144143 | | Inventor | COHEN, Robert, 120 Meadowview Drive
Newton, PA 18940, US,
CARR, Suzette, 579 Province Line Road
Hopewell, NJ 08525, US,
BECKER, Jean-Claude, 16 Halstead Place
Princeton, NJ 08543, US,
PEACH, Robert, J., 12848 Via Caballo Rojo
San Diego, CA 92129, US,
Hagerty, David, 215 Avenue De Monaco
Cardiff by the Sea, CA 92007, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61K 45/06 (2006.01) , A61P 19/02 (2006.01) , A61P 37/04 (2006.01) | | Title | ANVENDELSER AF OPLØSELIGE, MUTANTE CTLA4-MOLEKYLER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
